SGC-Oxford team comes out in support of Brain Tumour Charity’s Twilight Walk
On September 29th 2019, the Brain Tumour Charity organized The Twilight Walk in Warwick, UK, to raise funds for research and patient support. M4K Pharma’s DIPG project collaborators at the Structural Genomics Consortium (SGC)- University of Oxford took part in the event by hosting an activity booth and joining the walk.
The SGC team led by Dr. Alex Bullock receives funding from the Brain Tumour Charity to study ALK2 inhibitors for DIPG treatment.
— The Brain Tumour Charity (@BrainTumourOrg) October 15, 2017